Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

OneOme and St. Catherine Specialty Hospital in Croatia Partner to Increase Access to Pharmacogenetic Testing in Europe


MINNEAPOLIS and ZAGREB, Croatia, Oct. 15, 2018 /PRNewswire/ -- OneOme, co-founded with Mayo Clinic, announced today that they are partnering with St. Catherine Specialty Hospital, a European Center of Excellence, to bring innovative, actionable pharmacogenetic (PGx) testing to patients.

St. Catherine partners with OneOme

St. Catherine Specialty Hospital will offer its patients the OneOme RightMed® comprehensive test, a PGx test that uses a person's DNA to predict their response to hundreds of medications. Using the RightMed test results and OneOme's supporting technology, physicians at St. Catherine may prescribe more effective medications with fewer side effects.

"St. Catherine is well regarded across the globe for its high quality of care and for its innovative diagnostic and personalized treatment strategies," said Paul Owen, CEO of OneOme. "We look forward to further enhancing St. Catherine's level of care with the RightMed solution by helping its physicians optimize treatment strategies."

The RightMed test covers 27 genes and hundreds of medications used to treat 30 medical conditions, including cancer, pain, psychiatric disorders, and cardiovascular disease. The comprehensive coverage of the RightMed test provides PGx results that can be used for years to come when treating these medical conditions.

"We selected the RightMed test because of its scientific rigor and because it covers more genes and medications than any other product we identified," said Dr. Dragan Primorac, president of the Board of Trustees at St. Catherine Specialty Hospital. "We are particularly excited to provide clinical insights to guide the enhancement of OneOme's solution and for the potential the test holds in optimizing pain management."

St. Catherine and OneOme are also collaborating on a research study to evaluate pain management treatments for lower back pain.

About OneOme
OneOme was co-founded with Mayo Clinic to bringing pharmacogenetic (PGx) testing into routine clinical care. OneOme is a privately held company backed by early-stage venture firm Invenshure, LLC, and Mayo Clinic. To learn more about OneOme, visit oneome.com.

About St. Catherine Specialty Hospital
St. Catherine is a university teaching hospital and the official hospital of the Croatian Olympic Committee and of the Croatian Football Federation. The Hospital is the first European recipient of U.S. Global Healthcare Accreditation and known for introducing the integrative concept of personalized medicine in clinical practice. To learn more about St. Catherine, visit www.svkatarina.hr/en.

Contact:
Katie Mittelstadt
612-404-1076
[email protected]

Photo - https://mma.prnewswire.com/media/767027/St_Catherine.jpg
Logo - https://mma.prnewswire.com/media/626760/OneOme_Logo.jpg



These press releases may also interest you

at 17:50
Consolidated Communications Holdings, Inc. (the "Company" or "Consolidated") announced that it has completed the sale of its Washington assets, effective May 1, 2024, to Palisade Infrastructure. The divestiture aligns with the Company's ongoing...

at 17:40
VerticalScope Holdings Inc. ("VerticalScope"), a technology company that has built and operates a cloud-based digital platform for online enthusiast communities with 65 million registered users, today announced it has adopted The Trade Desk's...

at 17:35
Overcoming the longs odds of a life prison sentence, a year in solitary confinement, generational drug addiction and gang involvement 10 former felons who collectively served more than 100 years this week shared their journeys from incarceration to...

at 17:25
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the...

at 17:23
EVP Capital Inc. ("EVP Capital"), a capital pool company ("CPC") listed on the TSX Venture Exchange Inc. (the "Exchange"), is pleased to announce that it has entered into a non-binding letter of intent dated May 1, 2024 (the "LOI") with Sharp Edge...

at 17:20
SnapLogic, the leader in generative integration, today announced that it has been positioned by Aragon Research, Inc. as a Leader in the third annual Globetm for Transformation Platform as a Service. Download a complimentary copy of The Aragon...



News published on and distributed by: